Friday February 24th 2017: Shire plc, SHPG is in the exchange NASDAQ and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in Ireland, Shire plc, SHPG has a market cap of 50.02 B. Since its IPO date on the 3/25/1998, Shire plc, SHPG performance year to date is -3.55%. Today Shire plc, SHPG has gained -1.28%, with a current price of 162.24.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 22.10%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 0.40%, with return on investment at 2.10%.
In terms of debt levels and profit levels, Shire plc, SHPG is seeing a long-term debt/equity of 0.66. While Total debt/equity is 0.76. With a profit margin of 2.10%, this is combined with a gross margin of 63.10%, and operating margin of 6.90%. Shire plc ability to meet debt levels, with a current ratio of 1, while the quick ratio is 0.5.
For the last year Shire plc, SHPG has seen a EPS growth of -65.50%. A performance for the year of -15.86%. The 52-week high is -22.45%, and the 52-week low is 2.11%. The average volume for Shire plc, SHPG is 445954.
With a target price of 238.75, can Shire plc, SHPG reach this target? Looking at the value indicators of Shire plc, SHPG. Shire plc has a P/E of 88.45 and a forward P/E of 9.8. Perhaps the more useful indicator than P/E, is PEG which has a value of 6.8. Shire plc also has a P/S and a P/B of 3.77 and 1.67 respectively. For P/cash, Shire plc has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 162.24, Shire plc has a dividend yield of 0.55%. We see a return on equity of 1.00%.
Looking more long-term Shire plc, is projected to get an EPS growth for the next five years of 13.00%. In the short-term an EPS growth of 12.67% in the next year is forecasted. This is after a EPS growth of -65.50% for this year and for the last five years a -12.80% growth has been seen.